Published in Eur J Nucl Med Mol Imaging on August 01, 2010
Relationship between baseline brain metabolism measured using [¹⁸F]FDG PET and memory and executive function in prodromal and early Alzheimer's disease. Brain Imaging Behav (2012) 0.96
Volume of interest-based [18F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study. Neuroimage Clin (2014) 0.84
Impulsivity is Associated with Increased Metabolism in the Fronto-Insular Network in Parkinson's Disease. Front Behav Neurosci (2015) 0.75
Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome. JAMA (2001) 5.13
Relationships between biomarkers in aging and dementia. Neurology (2009) 4.16
The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core. Alzheimers Dement (2010) 3.30
Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias. J Nucl Med (2008) 2.92
Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Neuroimage (2009) 2.80
Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease. AJNR Am J Neuroradiol (2010) 2.61
Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline. Eur J Neurol (2007) 2.47
Comparison of 18F-FDG and PiB PET in cognitive impairment. J Nucl Med (2009) 1.90
Performance of FDG PET for detection of Alzheimer's disease in two independent multicentre samples (NEST-DD and ADNI). Dement Geriatr Cogn Disord (2009) 1.18
Mapping brain morphological and functional conversion patterns in amnestic MCI: a voxel-based MRI and FDG-PET study. Eur J Nucl Med Mol Imaging (2010) 1.10
Current Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF Studies. J Clin Neurol (2009) 1.06
Fluorodeoxyglucose-positron emission tomography in the differential diagnosis of early-onset dementia: a prospective, community-based study. BMC Neurol (2009) 0.95
Regional cerebral glucose metabolism in aging and senile dementia as determined by 18F-deoxyglucose and positron emission tomography. Exp Brain Res (1982) 0.92
MCI patients declining and not-declining at mid-term follow-up: FDG-PET findings. Curr Alzheimer Res (2010) 0.89
Differences in hippocampal metabolism between amnestic and non-amnestic MCI subjects: automated FDG-PET image analysis. Q J Nucl Med Mol Imaging (2009) 0.86
Multi-center study on Alzheimer's disease using FDG PET: group and individual analyses. J Alzheimers Dis (2010) 0.79
Autopsy as gold standard in FDG-PET studies in dementia. Can J Neurol Sci (2010) 0.75
EANM procedure guidelines for brain neurotransmission SPECT using (123)I-labelled dopamine transporter ligands, version 2. Eur J Nucl Med Mol Imaging (2010) 2.09
Čerenkov radioactive optical imaging: a promising new strategy. Eur J Nucl Med Mol Imaging (2011) 1.69
EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2. Eur J Nucl Med Mol Imaging (2009) 1.49
EANM procedure guideline for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals, version 2. Eur J Nucl Med Mol Imaging (2009) 1.45
Patient and caregiver perspectives of quality of life in dementia. An investigation of the relationship to behavioural and psychological symptoms in dementia. Dement Geriatr Cogn Disord (2008) 1.41
Neuropsychiatric syndromes in dementia. Results from the European Alzheimer Disease Consortium: part I. Dement Geriatr Cogn Disord (2007) 1.38
Prediction of Alzheimer disease in subjects with amnestic and nonamnestic MCI. Neurology (2013) 1.27
European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis. Eur J Nucl Med Mol Imaging (2012) 1.19
Individual analysis of EEG frequency and band power in mild Alzheimer's disease. Clin Neurophysiol (2004) 1.19
Local MRI analysis approach in the diagnosis of early and prodromal Alzheimer's disease. Neuroimage (2011) 1.15
Mapping distributed sources of cortical rhythms in mild Alzheimer's disease. A multicentric EEG study. Neuroimage (2004) 1.14
Brain hypermetabolism in amyotrophic lateral sclerosis: a FDG PET study in ALS of spinal and bulbar onset. Eur J Nucl Med Mol Imaging (2011) 1.11
Consistency of neuropsychiatric syndromes across dementias: results from the European Alzheimer Disease Consortium. Part II. Dement Geriatr Cogn Disord (2007) 1.10
Mapping brain morphological and functional conversion patterns in amnestic MCI: a voxel-based MRI and FDG-PET study. Eur J Nucl Med Mol Imaging (2010) 1.10
Grouping for behavioral and psychological symptoms in dementia: clinical and biological aspects. Consensus paper of the European Alzheimer disease consortium. Eur Psychiatry (2005) 1.09
Resting metabolic connectivity in prodromal Alzheimer's disease. A European Alzheimer Disease Consortium (EADC) project. Neurobiol Aging (2012) 1.09
The basal ganglia matching tools package for striatal uptake semi-quantification: description and validation. Eur J Nucl Med Mol Imaging (2007) 1.03
Sources of cortical rhythms change as a function of cognitive impairment in pathological aging: a multicenter study. Clin Neurophysiol (2005) 1.03
Fronto-parietal coupling of brain rhythms in mild cognitive impairment: a multicentric EEG study. Brain Res Bull (2005) 1.03
Summary metrics to assess Alzheimer disease-related hypometabolic pattern with 18F-FDG PET: head-to-head comparison. J Nucl Med (2012) 1.02
Abnormal fronto-parietal coupling of brain rhythms in mild Alzheimer's disease: a multicentric EEG study. Eur J Neurosci (2004) 1.00
Directionality of EEG synchronization in Alzheimer's disease subjects. Neurobiol Aging (2007) 1.00
Frontal white matter volume and delta EEG sources negatively correlate in awake subjects with mild cognitive impairment and Alzheimer's disease. Clin Neurophysiol (2006) 0.99
Value of semiquantitative analysis for clinical reporting of 123I-2-β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl)nortropane SPECT studies. J Nucl Med (2013) 0.98
Brain morphometry reproducibility in multi-center 3T MRI studies: a comparison of cross-sectional and longitudinal segmentations. Neuroimage (2013) 0.97
Sources of cortical rhythms in adults during physiological aging: a multicentric EEG study. Hum Brain Mapp (2006) 0.96
Do instrumental activities of daily living predict dementia at 1- and 2-year follow-up? Findings from the Development of Screening guidelines and diagnostic Criteria for Predementia Alzheimer's disease study. J Am Geriatr Soc (2011) 0.93
Metabolic networks underlying cognitive reserve in prodromal Alzheimer disease: a European Alzheimer disease consortium project. J Nucl Med (2013) 0.92
Resting EEG sources correlate with attentional span in mild cognitive impairment and Alzheimer's disease. Eur J Neurosci (2007) 0.92
Appropriate use criteria for amyloid PET imaging cannot replace guidelines: on behalf of the European Association of Nuclear Medicine. Eur J Nucl Med Mol Imaging (2013) 0.90
The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients. Eur J Nucl Med Mol Imaging (2014) 0.90
Association between white matter hyperintensities and executive decline in mild cognitive impairment is network dependent. Neurobiol Aging (2010) 0.89
No association between striatal dopamine transporter binding and body mass index: a multi-center European study in healthy volunteers. Neuroimage (2012) 0.89
Brain perfusion correlates of medial temporal lobe atrophy and white matter hyperintensities in mild cognitive impairment. J Neurol (2007) 0.88
Statistical parametric mapping of (99m)Tc-HMPAO-SPECT images for the diagnosis of Alzheimer's disease: normalizing to cerebellar tracer uptake. Neuroimage (2002) 0.87
Stability of clinical condition in mild cognitive impairment is related to cortical sources of alpha rhythms: an electroencephalographic study. Hum Brain Mapp (2010) 0.87
Cortical sources of resting EEG rhythms in mild cognitive impairment and subjective memory complaint. Neurobiol Aging (2008) 0.87
Measurements of medial temporal lobe atrophy for prediction of Alzheimer's disease in subjects with mild cognitive impairment. Neurobiol Aging (2013) 0.87
Principal component analysis in mild and moderate Alzheimer's disease--a novel approach to clinical diagnosis. Psychiatry Res (2009) 0.85
Traditional and non traditional risk factors in accelerated atherosclerosis in systemic lupus erythematosus: role of vascular endothelial growth factor (VEGATS Study). Autoimmun Rev (2008) 0.85
What predicts cognitive decline in de novo Parkinson's disease? Neurobiol Aging (2012) 0.85
Extrastriatal binding of [¹²³I]FP-CIT in the thalamus and pons: gender and age dependencies assessed in a European multicentre database of healthy controls. Eur J Nucl Med Mol Imaging (2014) 0.84
Quantitative EEG and perfusional single photon emission computed tomography correlation during long-term donepezil therapy in Alzheimer's disease. Clin Neurophysiol (2004) 0.83
Quantitative EEG changes in Alzheimer patients during long-term donepezil therapy. Neuropsychobiology (2002) 0.83
Donepezil effects on sources of cortical rhythms in mild Alzheimer's disease: Responders vs. Non-Responders. Neuroimage (2006) 0.83
Assessment of dementia in ethnic minority patients in Europe: a European Alzheimer's Disease Consortium survey. Int Psychogeriatr (2010) 0.82
Doctor, what does my future hold? The prognostic value of FDG-PET in solid tumours. Eur J Nucl Med Mol Imaging (2010) 0.82
Automatic analysis of medial temporal lobe atrophy from structural MRIs for the early assessment of Alzheimer disease. Med Phys (2009) 0.82
EANM procedure guidelines for brain neurotransmission SPECT/PET using dopamine D2 receptor ligands, version 2. Eur J Nucl Med Mol Imaging (2010) 0.82
No difference in striatal dopamine transporter availability between active smokers, ex-smokers and non-smokers using [123I]FP-CIT (DaTSCAN) and SPECT. EJNMMI Res (2013) 0.81
Cortical sources of resting state electroencephalographic alpha rhythms deteriorate across time in subjects with amnesic mild cognitive impairment. Neurobiol Aging (2013) 0.81
Mitochondrial function is related to alterations at brain SPECT in depressed patients. CNS Spectr (2008) 0.80
Cortical sources of awake scalp EEG in eating disorders. Clin Neurophysiol (2007) 0.79
Cortical sources of resting state EEG rhythms are sensitive to the progression of early stage Alzheimer's disease. J Alzheimers Dis (2013) 0.79
Quality of life and brain function following high-dose recombinant human erythropoietin in low-risk myelodysplastic syndromes: a preliminary report. Eur J Haematol (2004) 0.79
Neuroimaging features in C9orf72 and TARDBP double mutation with FTD phenotype. Neurocase (2014) 0.78
Right hemispheric dysfunction in a case of pure progressive aphemia: fusion of multimodal neuroimaging. Psychiatry Res (2004) 0.78
Predicting progression from cognitive impairment to Alzheimer's disease with the Disease State Index. Curr Alzheimer Res (2015) 0.78
Correlation between Doppler velocities and duplex ultrasound carotid cross-sectional percent stenosis. Acad Radiol (2011) 0.78
Cognitive impairment in degenerative parkinsonisms: role of radionuclide brain imaging. Q J Nucl Med Mol Imaging (2012) 0.78
Predicting the accuracy of a diagnosis of Alzheimer's disease with 99mTc HMPAO single photon emission computed tomography. Psychiatry Res (2004) 0.78
99mTc-HMPAO and 99mTc-ECD perform differently in typically hypoperfused areas in Alzheimer's disease. Eur J Nucl Med Mol Imaging (2003) 0.77
Stroop interference task and single-photon emission tomography in anorexia: a preliminary report. Int J Eat Disord (2005) 0.77
PET-guided prostate cancer radiotherapy: technological innovations for dose delivery optimisation. Eur J Nucl Med Mol Imaging (2010) 0.77
Plasma antioxidants and brain glucose metabolism in elderly subjects with cognitive complaints. Eur J Nucl Med Mol Imaging (2013) 0.77
Identification by [99mTc]ECD SPECT of anterior cingulate hypoperfusion in progressive supranuclear palsy, in comparison with Parkinson's disease. Eur J Nucl Med Mol Imaging (2007) 0.77
A repository based on a dynamically extensible data model supporting multidisciplinary research in neuroscience. BMC Med Inform Decis Mak (2012) 0.77
Multi-center comparison of medial temporal atrophy in patients with Alzheimer's disease--data from the ICTUS study. Dement Geriatr Cogn Disord (2008) 0.76
Monitoring cancer therapy with PET: probably effective, but more research is needed. Eur J Nucl Med Mol Imaging (2009) 0.76
Radiation burden in myocardial imaging: an old concern in the new age of hi-tech, hybrid imaging. Eur J Nucl Med Mol Imaging (2010) 0.76
Late Persistent Increased Putaminal 18F-DOPA Uptake Following Ipsilateral Frontal Resection: Evidence for Corticostriatal Synaptic Plasticity? Clin Nucl Med (2015) 0.75
Seizures can precede cognitive symptoms in late-onset Alzheimer's disease. J Alzheimers Dis (2011) 0.75
Frontal Variant Alzheimer Disease or Frontotemporal Lobe Degeneration With Incidental Amyloidosis? Alzheimer Dis Assoc Disord (2016) 0.75
Agomelatine Improves Apathy in Frontotemporal Dementia. Neurodegener Dis (2016) 0.75
Brain (18)F-DOPA PET and cognition in de novo Parkinson's disease. Eur J Nucl Med Mol Imaging (2015) 0.75
Effectiveness of Florbetapir PET Imaging in Changing Patient Management. Dement Geriatr Cogn Disord (2017) 0.75
The short cognitive evaluation battery in cognitive disorders of the elderly--Italian version. Dement Geriatr Cogn Disord (2012) 0.75
Screening of Early and Late Onset Alzheimer's Disease Genetic Risk Factors in a Cohort of Dementia Patients from Liguria, Italy. Curr Alzheimer Res (2015) 0.75
Whole body and cardiac metaiodobenzylguanidine kinetics in Parkinson disease and multiple system atrophy: implications for the diagnostic role of imaging. Clin Nucl Med (2010) 0.75
Impaired access to semantic memory for the cognition of geographic space in Alzheimer's disease. Arch Gerontol Geriatr (2009) 0.75